Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 15,310.00p on 25-02-2026 at 09:37:09
Change -16.00p -0.1%
Buy 15,312.00p
Sell 15,308.00p
Last Trade: Unknown 0.00 at 15,312.00p
Day's Volume: 97,918
Last Close: 15,326.00p
Open: 15,316.00p
ISIN: GB0009895292
Day's Range 15,232.00p - 15,320.00p
52wk Range: 9,574.00p - 15,730.00p
Market Capitalisation: £237.35b
VWAP: 15,286.8106p
Shares in Issue: 1.55b

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 0 15,312.00p SI Trade
09:37:09 - 25-Feb-26
Unknown* 0 15,312.00p SI Trade
09:37:06 - 25-Feb-26
Sell* 15 15,310.00p Automatic Execution
09:37:05 - 25-Feb-26
Buy* 1 15,310.00p Automatic Execution
09:37:05 - 25-Feb-26
Sell* 8 15,308.00p Automatic Execution
09:37:05 - 25-Feb-26
Buy* 23 15,308.00p Automatic Execution
09:37:04 - 25-Feb-26
Sell* 14 15,306.00p Automatic Execution
09:37:04 - 25-Feb-26
Sell* 14 15,304.00p Automatic Execution
09:37:04 - 25-Feb-26
Sell* 14 15,304.00p Automatic Execution
09:37:04 - 25-Feb-26
Sell* 14 15,304.00p Automatic Execution
09:37:03 - 25-Feb-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Feb 2026 (Wed) 15,316.00 15,320.00 15,232.00 15,326.00 97,918
24th Feb 2026 (Tue) 15,206.00 15,554.00 15,184.00 15,326.00 6,767,639
23rd Feb 2026 (Mon) 15,188.00 15,356.00 15,080.00 15,344.00 3,471,752
20th Feb 2026 (Fri) 15,422.00 15,424.00 15,224.00 15,270.00 7,485,202
19th Feb 2026 (Thu) 15,390.00 15,426.00 15,162.00 15,290.00 1,991,093
18th Feb 2026 (Wed) 15,498.00 15,730.00 15,484.00 15,542.00 1,448,505
17th Feb 2026 (Tue) 15,174.00 15,522.00 15,174.00 15,522.00 2,510,009
16th Feb 2026 (Mon) 15,186.00 15,188.00 14,944.00 15,160.00 2,085,798
13th Feb 2026 (Fri) 14,986.00 15,186.00 14,816.00 15,118.00 6,247,443
12th Feb 2026 (Thu) 14,918.00 15,028.00 14,782.00 14,906.00 1,393,202
11th Feb 2026 (Wed) 14,118.00 14,818.00 14,074.00 14,818.00 3,601,531
10th Feb 2026 (Tue) 13,952.00 14,314.00 13,748.00 14,164.00 3,682,197
9th Feb 2026 (Mon) 14,184.00 14,250.00 13,858.00 13,888.00 4,085,396
6th Feb 2026 (Fri) 13,884.00 14,112.00 13,846.00 14,104.00 3,108,416
5th Feb 2026 (Thu) 13,790.00 14,068.00 13,696.00 13,980.00 1,437,883
4th Feb 2026 (Wed) 13,472.00 13,926.00 13,444.00 13,796.00 2,067,316
3rd Feb 2026 (Tue) 13,808.00 13,942.00 13,636.00 13,816.00 1,443,630
2nd Feb 2026 (Mon) 13,532.00 14,060.00 13,500.00 14,040.00 1,342,224
30th Jan 2026 (Fri) 13,328.00 13,600.00 13,326.00 13,600.00 1,640,379
29th Jan 2026 (Thu) 13,406.00 13,564.00 13,402.00 13,460.00 2,707,843
28th Jan 2026 (Wed) 13,818.00 13,822.00 13,478.00 13,508.00 2,526,744
27th Jan 2026 (Tue) 13,800.00 13,986.00 13,736.00 13,880.00 1,444,248
26th Jan 2026 (Mon) 13,642.00 13,770.00 13,560.00 13,752.00 1,555,763
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
24th Feb 2026 11:00 am RNS Annual Financial Report
24th Feb 2026 7:00 am RNS Directorate change
20th Feb 2026 7:00 am RNS Fixed-duration Calquence combo approved in US
10th Feb 2026 7:00 am RNS Final Results
3rd Feb 2026 7:00 am RNS Update on Saphnelo subcutaneous administration
2nd Feb 2026 3:00 pm RNS Total Voting Rights
2nd Feb 2026 7:05 am RNS Imfinzi recommended in EU for early gastric cancer
2nd Feb 2026 7:00 am RNS AstraZeneca begins trading on NYSE
30th Jan 2026 7:00 am RNS AstraZeneca agrees obesity and T2D deal with CSPC
29th Jan 2026 9:51 am RNS AstraZeneca invests $15bn in China through 2030
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

Avacta hails new data supporting proprietary preCision platform

24th Feb 2026 11:06

(Alliance News) - Avacta Group PLC on Tuesday saw its shares rise, as it said new data demonstrates a favourable delivery profile and advantages of its preCision platform when compared to a marketed antibody drug conjugate. Read More

LONDON MARKET OPEN: Stocks fall after latest tariff salvo

23rd Feb 2026 08:51

(Alliance News) - Stock prices in Europe moved lower in early dealings on Monday, with enthusiasm at the start of the week tempered by tariff uncertainty, as US President Donald Trump hit out at a Supreme Court ruling and announced new trade curbs. Read More

US regulator FDA greenlights AbbVie and AstraZeneca's cancer treatment

20th Feb 2026 10:45

(Alliance News) - AbbVie Inc and AstraZeneca PLC on Friday hailed a regulatory win for their joint cancer treatment programme. Read More

LONDON BROKER RATINGS: Three brokers cut Unilever to 'hold' from 'buy'

18th Feb 2026 09:30

(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday: Read More

LONDON BROKER RATINGS: RBC cuts Schroders, LBBW says 'hold' Unilever

16th Feb 2026 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,777.76
Change97.17

Login to your account

Forgot Password?

Not Registered